αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/ABT

ABT

ABT 13F Ownership Report

Abbott Laboratories

-$24.0B

Net Activity

Data as of: 2026-03-31

Institutions Holding

3086

Popularity Rank

#46

Avg Weight

0.32%

Total Value

$142.7B

Ownership Trend

ABT (Abbott Laboratories) institutional ownership chart showing 3086 institutional holders, buyer vs. seller counts, and net quarterly capital flow

3086 institutions currently hold ABT, with 1256 net buyers and 1739 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

1739

Net Buying Institutions

1256

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$15.0B
VC
Vanguard Capital Management LLC
$11.6B
SS
State Street CORP
$8.2B
CR
Capital Research Global Investors
$5.1B
VP
Vanguard Portfolio Management LLC
$4.9B

Top 5 by Conviction

FV
Flossbach Von Storch Se
3.76%
DH
Diamond Hill Capital Management INC
3.45%
GM
Grantham, Mayo, Van Otterloo & Co. LLC
2.34%
FS
Fayez Sarofim & Co
1.12%
SF
State Farm Mutual Automobile Insurance Co
1.10%
View all 3086 holding institutions

Across its top 20 institutional holders, ABT's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 4/100, avg. turnover score 21/100).

Quarterly Activity

Recent Activity

+$56.9B

Total Buy Value

$100.7B

Total Sell Value

New buy147
Trim1432
Add1109
Sold out307

1256

Net Buyers

1739

Net Sellers

Game Theory Scenarios

Neutral— Wait & Watch

Institutional and Insider Signals Diverge to Neutral

Signal Basis

Broad institutional holders reduced positions by $24B (1,739 net sellers vs 1,256 net buyers), but a tightly concentrated group of 'guru' managers added $149M net. Insider activity shows net buying of +24,601 shares over 90 days ($3.1M buys vs $0.5M sells) yet purely selling over the final 30 days. The conflicting signals create a stalemate.

Confirmation

Continued divergence—broad institutional selling clashing with gurus buying and insiders fluctuating—would confirm the neutral thesis remains valid.

Invalidation Risk

A clear convergence either towards sustained broad institutional selling matched by insider selling (bearish) or smart money buying matched by insider buying (bullish) would invalidate the neutral assessment.

Generated by AI directly from institutional holders' Form 13F data on SEC EDGAR, reflecting past activity only. Not investment advice — do not base trading decisions on this alone; verify against the source filings below.

See the institutional 13F filings behind this signal

Smart Money Convergence

ABT does not currently show a 13F-and-insider convergence signal — its insider confidence score is 52/100, below the threshold this product uses to flag combined buying pressure.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/ABT

Insider Trading (Form 4)

5290d confidence

2

unique buyers

$3.10M

buy value

data as of 2026-07-24

12-Month Buy/Sell Activity

Jan 25
Apr 25
Jan 26
BuySell
ActionInsiderTitleDateValue
SellShroff EricSenior Vice President2026-03-02$82K
SellSalvadori Daniel Gesua SiveEVP AND GROUP PRESIDENT2026-03-02$102K
SellLouis H. MorroneEXECUTIVE VICE PRESIDENT2026-03-02$132K
SellMoreland Mary KEXECUTIVE VICE PRESIDENT2026-03-02$71K
SellMCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLER2026-03-02$68K
SellElizabeth C. CushmanEVP, GC AND SECRETARY2026-03-02$30K
BuySTARKS DANIEL JDirector2026-02-04$545K
BuySTARKS DANIEL JDirector2026-02-04$542K
View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-16
2026-07-16

Abbott Laboratories (ABT) released its second-quarter 2026 financial results on July 16, 2026, via a news release furnished as Exhibit 99.1 to this 8-K filing. The company reported both GAAP and non-GAAP measures, adjusting for items such as acquisition costs, legal reserves, and stock-based compensation. The filing does not include specific numbers itself, but the full earnings report is contained in the attached exhibit.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

002824100, 00282410 , 002824900, 002824950, 2824100

FAQ

Who are the top institutional investors holding ABBOTT LABORATORIES (ABT)?
Major stakeholders currently include BlackRock, Inc. ($15.0B), Vanguard Capital Management LLC ($11.6B), State Street CORP ($8.2B). Based on the latest 13F filings, there are a total of 3086 tracked investment funds and institutions maintaining positions in ABT.
What is the overall institutional sentiment toward ABT recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $24.0B, driven by 1256 managers accumulating shares while 1739 reduced their exposure.
Which institutions have been selling or reducing their ABT positions?
In the latest period, 1432 funds trimmed their holdings, and 307 managers completely exited their positions. The aggregate reported sell value was $100.7B.
Are there any notable investors adding ABT to their portfolios?
Yes, buying activity remains notable. 147 institutions opened new positions in {ticker}, and 1109 existing holders added to their shares. The total reported buy value for the quarter amounted to $56.9B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,605

Total reported value

$438.9B

2856 institutions currently hold both ABT and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

2702 institutions currently hold both ABT and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,029

Total reported value

$283.9B

2769 institutions currently hold both ABT and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access ABT's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/ABT

CLI

npx alphasmo stocks get ABT
Full API & MCP documentation →